Literature DB >> 22041346

Elevated depressive symptoms are associated with hypertriglyceridemia in Japanese male workers.

Fumihiko Kamezaki1, Shinjo Sonoda, Sei Nakata, Masahiro Okazaki, Masahito Tamura, Haruhiko Abe, Masaaki Takeuchi, Yutaka Otsuji.   

Abstract

OBJECTIVE: The aim of this study was to determine whether elevated depressive symptoms are associated with metabolic syndrome and its components in the Japanese population.
METHODS: Out of 1,386 male workers who underwent measurements of variables of metabolic syndrome components in their health checkup, 1,186 subjects (44.5 ± 9.6 years) completed the Zung self-rating depression scale (ZSDS) (response rate 85.6%). In this study, metabolic syndrome was defined according to the joint scientific statement proposed by 6 major organizations, including the International Diabetes Federation.
RESULTS: The overall frequency of elevated depressive symptoms (ZSDS scores ≥40) was 42.1% (n=499). The incidence of metabolic syndrome was significantly higher in subjects with elevated depressive symptoms than in those without (13.2% vs. 8.9%, p<0.05). Of all the metabolic syndrome components, mean triglyceride levels were significantly higher in subjects with elevated depressive symptoms than in those without [124.7 (95% confidence interval (CI): 117.8-131.7) mg/dL vs. 111.5 (95% CI: 107.2-115.9) mg/dL, p<0.05]. Consequently, hypertriglyceridemia (28.9% vs. 21.0%, p<0.01) was the main component correlated with the between-group difference of metabolic syndrome incidence. In the logistic regression analysis after adjustment for potential confounders, the odds ratio of the total ZSDS scores for the diagnosis of hypertriglyceridemia was 1.52 (95% CI: 1.13-2.04; p<0.01), and the major depressive symptom was psychomotor agitation (odds ratio: 1.47; 95% CI: 1.10-1.94; p<0.01).
CONCLUSION: This study showed that elevated depressive symptoms were associated with hypertriglyceridemia in Japanese male workers, which affected the clinical diagnosis of metabolic syndrome.

Entities:  

Mesh:

Year:  2011        PMID: 22041346     DOI: 10.2169/internalmedicine.50.5667

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  5 in total

1.  Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement?

Authors:  Ronette L Kolotkin; Kishore M Gadde; Craig A Peterson; Ross D Crosby
Journal:  Qual Life Res       Date:  2015-10-07       Impact factor: 4.147

2.  Association between lipid profile and depressive symptoms among Chinese older people: mediation by cardiovascular diseases?

Authors:  Yajun Liang; Zhongrui Yan; Chuanzhu Cai; Hui Jiang; Aiqin Song; Chengxuan Qiu
Journal:  Int J Behav Med       Date:  2014-08

3.  Total serum cholesterol, atherogenic indices and their longitudinal association with depressive symptoms among US adults.

Authors:  M A Beydoun; H A Beydoun; G A Dore; M T Fanelli-Kuczmarski; M K Evans; A B Zonderman
Journal:  Transl Psychiatry       Date:  2015-03-03       Impact factor: 6.222

4.  Brain-derived neurotrophic factor, but not body weight, correlated with a reduction in depression scale scores in men with metabolic syndrome: a prospective weight-reduction study.

Authors:  I-Te Lee; Chia-Po Fu; Wen-Jane Lee; Kae-Woei Liang; Shih-Yi Lin; Chu-Jen Wan; Wayne Huey-Herng Sheu
Journal:  Diabetol Metab Syndr       Date:  2014-02-13       Impact factor: 3.320

Review 5.  Harnessing the Power of Microbiome Assessment Tools as Part of Neuroprotective Nutrition and Lifestyle Medicine Interventions.

Authors:  Miguel Toribio-Mateas
Journal:  Microorganisms       Date:  2018-04-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.